Parschauer Karah Herdman

CIK 00016774555 companiesNOVATO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001677455

Recent Transactions

50 trades

Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2026-03-10$22.67/sh−3,508→ 66,820 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2026-03-06$21.40/sh−6,018→ 70,328 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2026-03-02$22.80/sh−8,135→ 76,346 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2026-03-01+11,137→ 84,408 total
Award
Evolus, Inc.$EOLS
Common Stock
2026-02-17+45,559→ 77,742 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2025-09-12$31.17/sh−2,450→ 73,271 total
Award
Tenaya Therapeutics, Inc.$TNYA
Stock Option (Right to buy)
2025-05-29+107,400→ 107,400 total
Sale
Evolus, Inc.$EOLS
Common Stock
2025-03-12$12.99/sh−12,888→ 32,183 total
Award
Evolus, Inc.$EOLS
Common Stock
2025-03-07+7,364→ 45,071 total
Award
Evolus, Inc.$EOLS
Stock Option (Right to Buy)
2025-03-07+11,146→ 11,146 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2025-03-03$42.10/sh−12,846→ 75,287 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2025-03-01+18,443→ 88,133 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Stock Option (Right to Buy)
2025-03-01+26,074→ 26,074 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2025-03-01+14,494→ 69,690 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2025-02-27$42.75/sh−760→ 54,991 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2025-02-27$42.93/sh−2,230→ 55,751 total
Award
Tenaya Therapeutics, Inc.$TNYA
Stock Option (Right to buy)
2024-10-18+34,000→ 34,000 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2024-06-12$45.00/sh−9,806→ 57,981 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Stock Option (Right to Buy)
2024-03-01+31,400→ 31,400 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2024-03-01$53.76/sh−3,756→ 67,340 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2024-03-01+957→ 70,739 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2024-03-01+17,800→ 69,782 total
Award
Evolus, Inc.$EOLS
Stock Option (Right to Buy)
2024-02-07+9,377→ 9,377 total
Award
Evolus, Inc.$EOLS
Common Stock
2024-02-07+6,464→ 37,707 total
Sale
Evolus, Inc.$EOLS
Common Stock
2024-01-30$13.14/sh−11,931→ 31,243 total
Award
Tenaya Therapeutics, Inc.$TNYA
Stock Option (Right to buy)
2023-06-09+29,532→ 29,532 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2023-05-04$45.00/sh−4,378→ 51,982 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Stock Option (Right to Buy)
2023-03-01+39,400→ 39,400 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2023-03-01$45.25/sh−3,161→ 56,139 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2023-03-01+22,000→ 59,101 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2023-03-01+2,663→ 37,101 total
Award
Evolus, Inc.$EOLS
Common Stock
2023-01-27+8,293→ 43,174 total
Award
Evolus, Inc.$EOLS
Stock Option (Right to Buy)
2023-01-27+11,789→ 11,789 total
Award
Tenaya Therapeutics, Inc.$TNYA
Stock Option (Right to buy)
2022-09-08+20,000→ 20,000 total
Award
Anebulo Pharmaceuticals, Inc.$ANEB
Stock Option (right to buy)
2022-04-21+30,425→ 30,425 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2022-03-07$62.95/sh−5,140→ 34,438 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Stock Option (Right to Buy)
2022-03-01+24,900→ 24,900 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2022-03-01+14,000→ 39,578 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2022-03-01$66.62/sh−2,886→ 25,472 total
Award
Evolus, Inc.$EOLS
Common Stock
2022-01-24+15,568→ 34,881 total
Award
Evolus, Inc.$EOLS
Stock Option (Right to Buy)
2022-01-24+22,727→ 22,727 total
Award
Tenaya Therapeutics, Inc.$TNYA
Stock Option (Right to Buy)
2021-12-22+19,495→ 19,495 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2021-10-14$81.14/sh−310→ 28,358 total
Exercise/Conversion
Ultragenyx Pharmaceutical Inc.$RARE
Stock Option (Right to Buy)
2021-09-08−7,336→ 17,664 total
Exercise/Conversion
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2021-09-08$54.50/sh+7,336→ 36,004 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2021-09-08$100.65/sh−7,336→ 28,668 total
Award
Arcturus Therapeutics Holdings Inc.$ARCT
Stock Option (right to buy)
2021-06-18+15,000→ 15,000 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2021-06-10$100.00/sh−1,329→ 28,668 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2021-05-06$113.67/sh−313→ 29,997 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2021-03-01$138.17/sh−3,970→ 30,227 total

Companies

Recent Filings

Address

C/O ULTRAGENYX PHARMACEUTICAL INC. 60 LEVERONI COURT

NOVATO, CA, 94949

View on SEC.gov